Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
199 Leser
Artikel bewerten:
(1)

Pharmacovigilance Outsourcing Market Size to Reach $9.65 Bn, Globally, by 2030 at 14.6% CAGR: Allied Market Research

Rise in preference for outsourcing services and increase in adverse drug reactions and drug toxicity drive the growth of the global pharmacovigilance outsourcing market.

PORTLAND, Ore., Aug. 25, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Pharmacovigilance Outsourcing Market by Type (Adverse Drug Reaction Capture (ADR), Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, and Enabling Architecture), Service Provider (Contract Research Organizations and Business Processing Outsourcing), and End User (Pharmaceutical Industry, Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the pharmacovigilance outsourcing industry generated $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030, registering a CAGR of 14.6% from 2021 to 2030.

Allied_Market_Research_Logo

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11280

Prime determinants of growth

Rise in preference for outsourcing services and increase in in adverse drug reactions and drug toxicity drive the growth of the global pharmacovigilance outsourcing market. However, lack of skilled professional and risks related to data security hinder the market growth. On the other hand, growing prospects in the emerging economies present new opportunities in the coming years.

Covid-19 Scenario

  • During the initial phase of coronavirus, the unavailability of proper medication leads to the utilization of different types of drugs. Which in turn, led to increased demand for pharmacovigilance outsourcing, owing to surge in incidences of adverse drug reactions.
  • The demand is likely to grow significantly as the research for new and more effective drugs is still going on.

The contract research organization segment to maintain its leadership status throughout the forecast period

Based on service provider, the contract research organization segment contributed to the highest market share in 2020, accounting for nearly one-third of the global pharmacovigilance outsourcing market, and is expected to maintain its leadership status throughout the forecast period. Furthermore, the segment is projected to manifest the highest CAGR of 14.8% from 2021 to 2030. This is attributed to various advantages of contract research organization such as cost-effective services, time saving processes, advanced technological needs, and evolving and complex regulatory requirements.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11280

The pharmaceutical industry segment to maintain its lead position during the forecast period

Based on end user, the pharmaceutical industry segment accounted for the highest market share, holding more than four-fifths of the global pharmacovigilance outsourcing market in 2020, and is expected to maintain its lead position during the forecast period. This is attributed to increase in adoption of outsourcing services by pharmaceutical industry to avoid high upfront investments and fixed overhead costs, rise in resource flexibility, and secure additional capacity. However, the research organization segment is estimated to grow at the largest CAGR of 15.7% from 2021 to 2030.

North America to continue its highest contribution by 2030

Based on region, North America held the highest market share in terms of revenue with more than two-fifths of the global pharmacovigilance outsourcing market in 2020, and is estimated to continue its highest contribution by 2030. This is attributed to the presence of major pharma and medical device companies in the region. However, Asia-Pacific is projected to register the fastest CAGR of 16.5% during the forecast period. This is due to strict regulations for reporting adverse drug reactions coupled with large number of companies offering pharmacovigilance outsourcing services across the region.

Leading market players

  • Accenture PLC.
  • Bioclinica
  • Capgemini (IGate Corporation)
  • Cognizant Technology Solutions Corporation
  • Ergomed Plc.
  • Genpact Limited
  • International Business Machines Corporation
  • Icon Plc.
  • IQVIA Holdings Inc. (Clintec)
  • Labcorp Drug Development (Covance).

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Contrast Media Injectors Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Ligation Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Genome Editing Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

North America Workplace Wellness Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Monoclonal Antibodies Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Fertility Test Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

U.S. Home Medical Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

© 2021 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.